INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2) | MicrobiomeTrials← Back to trialsNCT07341958
INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-02-01Est. Completion: 2026-12-01
Enrollment target: 242 participants Locations- Beijing Tiantan Hopital, Capital Medical University, Beijing, China
Other microbiome trials you might be interested in
StrokeSleep-disordered BreathingSleep Apnea SyndromesSleep Apnea, ObstructiveSleep Apnea, CentralFragmentation, Sleep
This prospective cohort study aims to compare the proportion of cardiac or cerebrovascular events after a first stroke, …
Grenoble, FranceEst. completion Jun 1, 2030